Affecting factors to effectiveness of starting therapy in children with hiv infection

The purpose of the research – to characterize of the factors that influence the effectiveness of the starting highly activе antiretroviral therapy in children with HIV infection.

Materials and methods. A total of 67 children with HIV infection
at the age from 24 to 36 months who have not received antiretroviral treatment. Patients received highly activе antiretroviral therapy on clinical, immunological and laboratory indications. Regimen consisted of two HIV nucleoside reverse transcriptase inhibitors (zidovudine and lamivudine) in combination with a nonnucleoside reverse transcriptase inhibitor or viral protease inhibitor. Аs the third component of the scheme in 22 patients (32,8%) used nevirapine, in 24 (35,8%) – lopinavir/ritonavir, in 21 children (31,3%) – nelfinavir. In the future, the effectiveness of treatment was assessed by clinical parameters, the number of CD4 lymphocytes in the blood and HIV blood viral load. Data on the duration of the effectiveness of conservation regimens examined using Cox proportional hazard model.

Results. Duration of highly activу antiretroviral therapy was 12–79 months (median 28 months, interquartile range 13–60 months). In 55,2% patients, achieved sustained viral suppression (viral load levels below the level of test system sensitivity), improving the immune status (increase number of CD4 lymphocytes), the positive dynamics of clinical symptoms. In 37,3% patients, initial regimen was modified because of its inefficiency, which is often due to the inability to completely suppress viral replication (37,5%) and improve immune status (8,9%). Side effects occurred in 28,4% children, but only in 7,5% patients they were the cause of change therapies. When testing the clinical and laboratory parameters prior to treatment in the Cox model revealed that an independent factor increasing the duration of the effectiveness
of homepage conservation regimen was the appointment of lopinavir/ritonavir.

Conclusion. The results will contribute to the effectiveness of highly activе antiretroviral therapy of HIV infection in children with her long-term use.

1. Selected lectures on HIV-infection / Ed. by V.V. Pokrovsky. Мoscow; Geotar-Media, 2015 (in Russian).

2. Voronin E.E. HIV infection in children. Features of a current and therapy / In «Human Immunodeficiency Virus – Medicine» / Ed. by N.A. Belyakov, A.G. Rahmanova / E.E. Voronin, K.N. Dodonov. St. Petersburg; Baltic Education Centre, 2012 (in Russian).

3. Simovanyan E.N. / E.N. Simovanyan, V.B. Denisenko. Pediatricheskaya farmakologiya. 2010; 2: 41-5 (in Russian).

4. Afonina L.Yu. Features of antiretroviral therapy in children with HIV-infection / In «HIV and AIDS: National guidelines» / Ed. by V.V. Pokrovsky / L.Yu. Afonina, O.G. Yurin, E.E. Voronin, Yu.A. Fomin. Moscow; Geotar-Media, 2014 (in Russian).

5. Bartlett G. Clinical aspects of HIV infection – 2012 /G. Bartlett, G. Gallant, P. Fam. Мoscow; R. Valent, 2012 (in Russian).

6. Timchenko V.N. / V.N. Timchenko, Yu.A. Arhipova, N.D. Dzhangavadze. Zhurnal infektologii. 2013; 1: 63-8 (in Russian).

7. Denisenko V.B. / V.B. Denisenko, E.N. Simovanyan, E.V. Beketova. Pediatricheskaya farmakologiya. 2010; 1: 62-7 (in Russian).

8. Calmy A.L., Ford N. Improving treatment outcome for children with HIV. Lancet. 2011; 377 (9777): 1546-48.

9. Diagnosis of HIV infection and the use of antiretroviral drugs in children. National clinical guidelines / L.Yu. Afonina [et al.]. St. Petersburg, 2014 (in Russian).

10. Antiretroviral therapy for HIV infection in infants and children: towards universal access. Geneva; World Health Organization (WHO), 2010. 194 p.

11. Eisenhut M. An update on HIV in children. Paed. and Child Health. 2013; 23 (3): 109-14.

12. Order of the Ministry of health and social development of the Russian Federation on March 17, 2006 № 166 «On approval of the Instructions for completing the annual forms of federal statistical observation N 61 «Information on the group of patients with HIV-infection». Мoscow, 2006 (in Russian).

13. Hoffmann K. Treatment of HIV Infection – 2011 / K. Hoffmann, Yu.K. Rokshtro. Мoscow; R. Valent, 2011 (in Russian).